Chicago filed a lawsuit against five pharmaceutical companies, accusing them of concealing the risks associated with certain painkillers.» Read More
Opana is produced by Endo Pharmaceuticals. The blood disorder, thrombotic thrombocytopenic purpura, resulted in kidney failure requiring dialysis in some cases, and at least one death, the Food and Drug Administration said. The FDA said problems appear to occur with Opana ER only when it is abused and injected intravenously.
Oct 9- Endo Health Solutions Inc:. Reuters Station users, click. 1568. Reuters Station users, click. 4899.
Oct 5- Endo Health Solutions Inc:. *Oppenheimer cuts Endo Health Solutions Inc price target to $42 from. Reuters Station users, click. 1568.
Oct 5- Endo Health Solutions Inc:. *UBS cuts Endo Pharmaceuticals price target to $45 from $50; rating. Reuters Station users, click. 1568.
Oct 5- Endo Health Solutions Inc:. *ThinkEquity cuts Endo Health Solutions price target to $40 from $45;. Reuters Station users, click. 1568.
Oct 5- Endo Health Solutions Inc:. *RBC cuts Endo Health Solutions Inc to sector perform from outperform. Reuters Station users, click. 1568.
The S&P 500 rose for a fourth session after a report suggested improvement in the labor market ahead of Friday's closely watched monthly payrolls report. The Nasdaq Composite Index gained 6.10 points, or 0.19 percent, to 3,141.40. **COLLABRX INC, $6.80, up 79.4 pct.
Oct 3- Endo Health Solutions Inc:. *Credit Suisse cuts Endo Health Solutions target price to $36 from. Reuters Station users, click. 1568.
Oct 1- Endo Health Solutions Inc:. *Cantor cuts Endo Health Solutions price target to $31 from $37;. Reuters Station users, click. 1568.
Jon Najarian has spotted unusual options activity in a top pharma name and an under the radar communications company. Find out what he makes of it!
Stocks closed narrowly mixed in thin trading Monday despite a flurry of M&A activity as investors cautiously awaited the start of earnings season. Travelers gained, while Chevron fell.
Stocks traded lower in thin trading Monday amid a lack of economic news and as investors cautiously awaited the start of earnings season. Travelers rose, while Chevron fell.
Stocks gained modestly as investors braced for the start of earnings season amid M&A activity. 3M rises, while Caterpillar falls.
Stock index futures pointed to a slightly higher open on Wall Street ahead of earnings season, which kicks off after the bell when Alcoa releases results.
With the markets on a decline, investors need to put money into value plays, said Rob Hoxton, president and CEO of Hoxton Financial, and Robert Auer, portfolio manager at Auer Growth Fund.
Stocks ended slightly down from Wednesday's record high levels, shrugging off news of economic strength from several economic reports. AmEx fell, while Alcoa rose.
Stocks stumbled from their record highs Thursday despite a handful of upbeat economic reports, although trading remained light in the final sessions of the year. AmEx fell, while Alcoa rose.
Stocks traded slightly down from record highs despite a batch of positive economic reports, including a surprising jump in pending home sales and a burst in Midwest manufacturing activity. AmEx fell, while Intel rose.
U.S. stock index futures strengthened but remained lower after the government reported a sharper than expected drop in jobless claims.
Following are moves you might have missed. Find out why shares of M&T Bank and JinkoSolar popped while Endo Pharmaceuticals and Stanley Black & Decker dropped.